Home / Pharmaceutical company intelligence
SAMI Pharmaceuticals Pvt. Ltd. logo
Pharmaceutical company intelligence

SAMI Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer and marketer of branded generic medicines across major therapeutic categories.

SAMI Pharmaceuticals products in Pakistan

SAMI Pharmaceuticals Pvt. Ltd has 188 medicine presentations registered in Pakistan under 67 brands, covering 63 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Endocrine & metabolic. Its brands with the most registered strengths and packs are RYBIO (Ribavirin), TELARB-Plus (Telmisartan + Amlodipine), EMPOLI (Empagliflozin) and NOVIDAT (Ciprofloxacin). 188 products have an official DRAP price on MedInfoBase. See all 67 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
SAMI Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
34-C, Block-6, P.E.C.H.S., Karachi-75350, Pakistan · 75350
Phone
+92 21 34527490-92
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000072 Sami Pharmaceuticals (Pvt) Ltd. · Sindh
Formulation 000731 Sami Pharmaceuticals (Pvt) Ltd. · Sindh
Semi Basic Manufacture 000907 Sami Pharmaceuticals (Pvt) Ltd. · Sindh
Formulation 000938 Sami Pharmaceuticals (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000072 185 linked products · source seen 11 Nov 2026 View source ↗
DML 000938 3 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx330public portfolio records represented
REG286unique registrations represented
IDX188indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+140registry-only registrations
VER220registry-verified exact registrations
PKR188current validated price records
G63generic molecules in indexed catalogue
DF8dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage57%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage94%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSAMI Pharmaceuticals Pvt. Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sami-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026Anti-infectives95 · 51%Cardiovascular24 · 13%Endocrine & metabolic16 · 9%Oncology & immunology9 · 5%Vitamins, minerals & nutrition9 · 5%Hematology & thrombosis9 · 5%Gastrointestinal & hepatology9 · 5%Other therapeutic areas17 · 9%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSAMI Pharmaceuticals Pvt. Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sami-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026188presentationsTablet96 · 51%Injection44 · 23%Capsule16 · 9%Suspension16 · 9%Infusion11 · 6%Solution3 · 2%Other forms2 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSAMI Pharmaceuticals Pvt. Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sami-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026176comparable productsBelow peer median16 · 9%Near peer median60 · 34%Above peer median100 · 57%Company median price position+6.6%Lowest-price equivalents11Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSAMI Pharmaceuticals Pvt. Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sami-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026M/s. Genix Pharma (Pvt) Ltd.40 shared63% overlapMacter International Limited40 shared63% overlapHIGH-Q Pharmaceuticals39 shared62% overlapNabiqasim Industries (Pvt) Ltd.,38 shared60% overlapTABROS PHARMA (PVT). LTD.38 shared60% overlapBosch Pharmaceuticals (Pvt) Ltd.37 shared59% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet96 products
Injection44 products
Capsule16 products
Suspension16 products
Infusion11 products
Solution3 products
Drops1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where SAMI Pharmaceuticals Pvt. Ltd. is priced against the market

176 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers145Distinct registrations among indexed, published, presentation-validated products only
Verified price observations188
Products with a verified price188
Products with multiple price observations0
Source records with multiple versions188
Latest portfolio source check12 Oct 2026
Latest effective price date4 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

286 unique registration(s) · 188 indexed presentation(s) · 2 additional source-observed presentation(s) · 140 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
CARICEF Cefixime 100 mg/5 mL Suspension 30 ml 022415 PKR 365.33 PKR 12.18/mL 🔒 Pharma Pro
CARICEF Cefixime 400 mg Capsule 5's 022416 PKR 654.67 PKR 130.93/capsule 🔒 Pharma Pro
CARICEF Cefixime 200 mg/5 mL Suspension 30 ml 044340 PKR 447.08 PKR 14.90/mL 🔒 Pharma Pro
CARICEF Cefixime 200 mg Tablet 10's 070790 PKR 648.51 PKR 64.85/tablet 🔒 Pharma Pro
Caricef 400mg TabletRegistry verified Cefixime — — — 070789Official source ↗ No indexed price — —
CERN-C Ascorbic acid 500 mg Tablet 4x10's 114675 PKR 80.22 PKR 2.01/tablet 🔒 Pharma Pro
Cynfo Fosfomycin 1 g Powder for IV infusion 1's 089069 PKR 82.16 PKR 82.16/vial/unit No comparator
D-TRES Cholecalciferol 5 mg/mL Injection 1's 076115 PKR 283.27 PKR 283.27/vial/unit 🔒 Pharma Pro
D-TRES Cholecalciferol 5 mg Injection 5's 076115 PKR 1,241.88 PKR 248.38/vial/unit 🔒 Pharma Pro
Delanzo DDR 30mg CapsulesRegistry verified Dexlansoprazole, Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole — — — 089145Official source ↗ No indexed price — —
Delanzo DDR 60mg CapsulesRegistry verified Dexlansoprazole — — — 089146Official source ↗ No indexed price — —
DEVAZO Daclatasvir 30 mg Tablet 28s 084766 PKR 5,710.84 PKR 203.96/tablet 🔒 Pharma Pro
DEVAZO Daclatasvir 60 mg Tablet 28s 084767 PKR 9,344.25 PKR 333.72/tablet 🔒 Pharma Pro
Dicloran 50mg TabletRegistry verified Diclofenac Sodium — — — 009744Official source ↗ No indexed price — —
Dicloran 75mg InjectionRegistry verified Diclofenac Sodium — — — 009748Official source ↗ No indexed price — —
Dicloran Disperlet Tablet 50mgRegistry verified Diclofenac Acid — — — 019172Official source ↗ No indexed price — —
Diclorep 50mg TabletRegistry verified Diclofenac Potassium — — — 022582Official source ↗ No indexed price — —
Diclorep 5Omg Sachet (Powder for Oral Suspension)Registry verified Diclofenac Potassium — — — 117994Official source ↗ No indexed price — —
Doctile 3gm SachetRegistry verified Dioctahedral smectite — — — 080299Official source ↗ No indexed price — —
Dultix DR 20mg CapsuleRegistry verified Duloxetine HCl — — — 089068Official source ↗ No indexed price — —
Dultix DR 30mg CapsuleRegistry verified Duloxetine HCl — — — 089067Official source ↗ No indexed price — —
Dultix DR 40mg CapsuleRegistry verified Duloxetine — — — 089066Official source ↗ No indexed price — —
Dultix DR 60mg CapsuleRegistry verified Duloxetine HCl — — — 089065Official source ↗ No indexed price — —
ECASIL Linezolid 600 mg Tablet 12's 066904 PKR 5,351.96 PKR 446.00/tablet 🔒 Pharma Pro
ECASIL Linezolid 400 mg Tablet 12's 067162 PKR 3,057.07 PKR 254.76/tablet 🔒 Pharma Pro
ECASIL Linezolid 200 mg/100 mL IV infusion 100ml Vial 067516 PKR 724.49 PKR 7.24/mL 🔒 Pharma Pro
ECASIL Linezolid 600 mg/300 mL IV infusion 300ml Vial 067518 PKR 1,256.33 PKR 4.19/mL 🔒 Pharma Pro
ECASIL Linezolid 100 mg/5 mL Suspension 60ml 076058 PKR 732.85 PKR 12.21/mL 🔒 Pharma Pro
EFFIFLOX Levofloxacin 250 mg Tablet 10's 037709 PKR 516.30 PKR 51.63/tablet 🔒 Pharma Pro
EFFIFLOX Levofloxacin 500 mg Tablet 10's 037710 PKR 859.18 PKR 85.92/tablet 🔒 Pharma Pro
Elinjec Injection 500mg /10mlRegistry verified Ferric Carboxymaltose Eq. to Iron Element — — — 108632Official source ↗ No indexed price — —
EMPOLI Empagliflozin 25 mg Tablet 7's 098701 PKR 812.60 PKR 116.09/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 25 mg Tablet 10's 098701 PKR 1,161.43 PKR 116.14/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 25 mg Tablet 14's 098701 PKR 1,625.18 PKR 116.08/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 25 mg Tablet 28's 098701 PKR 3,185.60 PKR 113.77/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 25 mg Tablet 30's 098701 PKR 3,413.29 PKR 113.78/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 10 mg Tablet 7's 098702 PKR 678.90 PKR 96.99/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 10 mg Tablet 10's 098702 PKR 969.26 PKR 96.93/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 10 mg Tablet 14's 098702 PKR 1,357.80 PKR 96.99/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 10 mg Tablet 28's 098702 PKR 2,661.27 PKR 95.05/tablet 🔒 Pharma Pro
EMPOLI Empagliflozin 10 mg Tablet 30's 098702 PKR 2,851.37 PKR 95.05/tablet 🔒 Pharma Pro
Empoli Plus Tablet 12.5 + 500mgRegistry verified Empagliflozin, Metformin hydrochloride — — — 107750Official source ↗ No indexed price — —
Empoli Plus Tablet 12.5 + 850mgRegistry verified Empagliflozin, Metformin hydrochloride — — — 107749Official source ↗ No indexed price — —
Empoli Plus Tablet 5 + 1000mgRegistry verified Empagliflozin, Metformin hydrochloride — — — 107751Official source ↗ No indexed price — —
Empoli Plus Tablet 5 + 850mgRegistry verified Empagliflozin, Metformin hydrochloride — — — 107752Official source ↗ No indexed price — —
Empoli Plus XR 10mg + 1000mg TabletRegistry verified Empagliflozin (as immediate release coating), Metformin hydrochloride (as extended release core) — — — 110030Official source ↗ No indexed price — —
Empoli Plus XR 12.5mg + 1000mg TabletRegistry verified Empagliflozin (as immediate release coating), Metformin hydrochloride (as extended release core) — — — 110031Official source ↗ No indexed price — —
Empoli Plus XR 25mg + 1000mg TabletRegistry verified Empagliflozin (as immediate release coating), Metformin hydrochloride (as extended release core) — — — 110029Official source ↗ No indexed price — —
Empoli Plus XR 5mg + 1000mg TabletRegistry verified Empagliflozin (as immediate release coating), Metformin hydrochloride (as extended release core) — — — 110028Official source ↗ No indexed price — —
Empoli Trio XR Tablet 10mg/5mg/ 1000mgRegistry verified Empagliflozin, Linagliptin, Metformin Hydrochloride — — — 120236Official source ↗ No indexed price — —
A to Z

All 67 SAMI Pharmaceuticals brands in Pakistan

  • ACTIM Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
  • ANTIAL Loratadine · 10 mg tablet, 5 mg/5 mL solution
  • Arcenate Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
  • ARCEVA Artemether + Lumefantrine, Artemether · 40 mg + 240 mg tablet, 80 mg + 480 mg tablet, 80 mg/mL injection
  • ARCEVA 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
  • ARILIO Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
  • ARNEZA Anastrozole · 1 mg tablet
  • AZITMA Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
  • BELIC Entecavir · 0.05 mg/mL solution, 1 mg tablet
  • BISLERI Iron polymaltose complex + Folic acid · 100 mg + 350 mcg capsule, 100 mg + 350 mcg tablet, 100 mg elemental iron + 350 mcg folic acid tablet
  • BREEKY Misoprostol · 200 mcg tablet
  • BRINO Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
  • Caffcit Caffeine citrate · 20 mg/mL infusion
  • CARICEF Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
  • CERN-C Ascorbic acid · 500 mg tablet
  • Cynfo Fosfomycin · 1 g infusion
  • D-TRES Cholecalciferol · 5 mg injection, 5 mg/mL injection
  • DEVAZO Daclatasvir · 30 mg tablet, 60 mg tablet
  • ECASIL Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
  • EFFIFLOX Levofloxacin · 250 mg tablet, 500 mg tablet
  • EMPOLI Empagliflozin · 10 mg tablet, 25 mg tablet
  • ENORIN Enoxaparin · 4000 IU injection, 6000 IU injection
  • Fungone Fluconazole · 100 mg/50 mL infusion, 150 mg capsule, 50 mg capsule
  • GLYMO-XR Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
  • Grasil Amikacin · 100 mg injection, 25 mg/1 mL injection, 250 mg injection
  • GRUDIZ Letrozole · 2.5 mg tablet
  • IDZO Midazolam · 5 mg/5 mL injection
  • KLINT Metronidazole · 200 mg/5 mL suspension, 400 mg tablet
  • KLINT Injection1 Metronidazole · 5 mg injection
  • Mdestiv Remdesivir · 100 mg infusion
  • Mefloq Mefloquine · 250 mg tablet
  • MOFEST Moxifloxacin · 400 mg tablet
  • NEOFIL Filgrastim (rHuG-CSF) · 300 mcg injection
  • NIVADOR Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Nivador AV Ceftazidime + Avibactam · 2 g + 0.5 g injection
  • NOVIDAT Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
  • Novidat XR Ciprofloxacin · 1000 mg tablet, 500 mg tablet
  • OCVIR Sofosbuvir · 400 mg tablet
  • OCVIR-V Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
  • OLMETHATE Colistimethate sodium · 1 MIU injection, 150 mg injection, 2 MIU injection
  • ONATO Amlodipine · 10 mg tablet, 5 mg tablet
  • ONTIV Ondansetron · 4 mg/2 mL injection, 8 mg tablet, 8 mg/4 mL injection
  • OSIRIS Quick Zinc · 10 mg tablet, 20 mg tablet
  • OXIDIL Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
  • PENORIT Norethisterone acetate + Ethinyl estradiol · 10 mg + 0.02 mg tablet
  • PLATRID Clopidogrel · 75 mg tablet
  • PROVAS Paracetamol · 120 mg/5 mL suspension, 250 MG/5 mL suspension, 500 mg tablet
  • Provas Fastiv Paracetamol · 500 mg tablet
  • RITHMO Clarithromycin · 250 mg tablet, 250 MG/5 mL suspension, 500 mg tablet
  • RITHMO 125mg Clarithromycin · 125 mg/5 mL drops, 125 mg/5 mL suspension
  • RITVY Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • ROLAC Itraconazole · 100 mg capsule
  • ROPO Erythropoietin · 10000 IU injection, 2000 IU injection, 4000 IU injection
  • RYBIO Ribavirin · 200 mg tablet, 400 mg tablet, 400 mg capsule
  • SALTIV Oseltamivir · 75 mg capsule
  • SAMCLOM Clomifene citrate · 50 mg tablet
  • SAMOCHIN Chloroquine · 250 mg tablet
  • SAMULIN R Regular human insulin · 100 IU/mL injection
  • SAMULIN-NPH Human insulin (isophane/NPH) · 100 IU/mL injection
  • TELARB-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
  • TELARB-Plus Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
  • TePH Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg infusion
  • TIMEQUIN Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule
  • TULAC Lactulose · 66.70 g/100 mL syrup
  • UBROF Ibuprofen · 400 mg/100 mL infusion, 600 mg/100 mL infusion, 800 mg/8 mL injection
  • VORY Voriconazole · 200 mg tablet, 200 mg/5 mL suspension, 50 mg tablet
  • ZIVALO of Zoledronic acid · 5 mg/100 mL solution
Questions

SAMI Pharmaceuticals: common questions

How many products does SAMI Pharmaceuticals have in Pakistan?

SAMI Pharmaceuticals Pvt. Ltd has 188 registered medicine presentations in Pakistan, sold under 67 brands and covering 63 generic medicines.

What are the main brands of SAMI Pharmaceuticals?

By number of registered strengths and packs, its largest brands are RYBIO (Ribavirin), TELARB-Plus (Telmisartan + Amlodipine), EMPOLI (Empagliflozin), NOVIDAT (Ciprofloxacin) and ARILIO (Tacrolimus). This is not a sales ranking.

Which therapy areas does SAMI Pharmaceuticals cover?

The most products are in Anti-infectives (95), Cardiovascular (24), Endocrine & metabolic (16), Oncology & immunology (9) and Vitamins, minerals & nutrition (9).

Where can I see SAMI Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). SAMI Pharmaceuticals Pvt. Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/sami-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9